NPY2R agonist therapy(Gubra)

N/A

Report date: 2024/03/26 17:36:41

Base Information

Drug NameNPY2R agonist therapy(Gubra)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuropeptide Y receptor type 2 agonists
TargetsNeuropeptide Y receptor type 2
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesGubra Aps
China Registration ClassN/A

Develop Information

Active CompaniesGubra ApsC.H. Boehringer Sohn Ag & Co. Kg
Inactive CompaniesN/A
Active IndicationsObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A